Diagnostic biomarkers of prostate cancer

References

• Heidenreich A, Aus G, Bolla M, Joniau S, Matveev VB, Schmid HP, EAU guidelines on prostate cancer. Eur Urol 2008;53:68–80.
   PubMed Web of Science ®Google Scholar
• Epstein JI, Herawi M. Prostate needle biopsies containing prostatic intraepithelial neoplasia or atypical foci suspicious for carcinoma: implications for patient care. J Urol 2006;175:820–34.
   PubMed Web of Science ®Google Scholar
• Fiorentino M, Capizzi E, Loda M. Blood and tissue biomarkers in prostate cancer: state of the art. Urol Clin North Am 2010;37:131–41.
   PubMed Web of Science ®Google Scholar
• Ross JS, Sheehan CE, Dolen EM, Kallakury BV. Morphologic and molecular prognostic markers in prostate cancer. Adv Anat Pathol 2002;9:115–28.
   PubMed Web of Science ®Google Scholar
• Zhou M, Shah R, Shen R, Rubin MA. Basal cell cocktail (34betaE12 + p63) improves the detection of prostate basal cells. Am J Surg Pathol 2003;27:365–71.
   PubMed Web of Science ®Google Scholar
• Beach R, Gown AM, De Peralta-Venturina MN, Folpe AL, Yaziji H, Salles PG, P504S immunohistochemical detection in 405 prostatic specimens including 376 18-gauge needle biopsies. Am J Surg Pathol 2002;26:1588–96.
   PubMed Web of Science ®Google Scholar
• Jiang Z, Woda BA, Rock KL, Xu Y, Savas L, Khan A, P504S: a new molecular marker for the detection of prostate carcinoma. Am J Surg Pathol 2001;25:1397–404.
   PubMed Web of Science ®Google Scholar
• Luo J, Zha S, Gage WR, Dunn TA, Hicks JL, Bennett CJ, Alpha-methylacyl-CoA racemase: a new molecular marker for prostate cancer. Cancer Res 2002;62:2220–6.
   PubMed Web of Science ®Google Scholar
• Magi-Galluzzi C, Luo J, Isaacs WB, Hicks JL, de Marzo AM, Epstein JI. Alpha-methylacyl-CoA racemase: a variably sensitive immunohistochemical marker for the diagnosis of small prostate cancer foci on needle biopsy. Am J Surg Pathol 2003;27:1128–33.
   PubMed Web of Science ®Google Scholar
• Zhou M, Jiang Z, Epstein JI. Expression and diagnostic utility of alpha-methylacyl-CoA-racemase (P504S) in foamy gland and pseudohyperplastic prostate cancer. Am J Surg Pathol 2003;27:772–8.
   PubMed Web of Science ®Google Scholar
• Farinola MA, Epstein JI. Utility of immunohistochemistry for alpha-methylacyl-CoA racemase in distinguishing atrophic prostate cancer from benign atrophy. Hum Pathol 2004;35:1272–8.
   PubMed Web of Science ®Google Scholar
• Uhlen M, Bjorling E, Agaton C, Szigyarto CA, Amini B, Andersen E, A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 2005;4:1920–32.
   PubMed Web of Science ®Google Scholar
• Jonmarker S, Glaessgen A, Culp WD, Pisa P, Lewensohn R, Ekman P, Expression of PDX-1 in prostate cancer, prostatic intraepithelial neoplasia and benign prostatic tissue. Apmis 2008;116:491–8.
   PubMed Web of Science ®Google Scholar
• Nilsson P, Paavilainen L, Larsson K, Odling J, Sundberg M, Andersson AC, Towards a human proteome atlas: high-throughput generation of mono-specific antibodies for tissue profiling. Proteomics 2005;5:4327–37.
   PubMed Web of Science ®Google Scholar
• Paavilainen L, Wernerus H, Nilsson P, Uhlen M, Hober S, Wester K, Evaluation of monospecific antibodies: a comparison study with commercial analogs using immunohistochemistry on tissue microarrays. Appl Immunohistochem Mol Morphol 2008;16:493–502.
   PubMedGoogle Scholar
• Reed JC. Mechanisms of apoptosis. Am J Pathol 2000;157:1415–30.
   PubMed Web of Science ®Google Scholar
• Osaka A, Hasegawa H, Yamada Y, Yanagihara K, Hayashi T, Mine M, A novel role of serum cytochrome c as a tumor marker in patients with operable cancer. J Cancer Res Clin Oncol 2009;135:371–7.
   PubMed Web of Science ®Google Scholar
• Yoo NJ, Soung YH, Lee SH. Absence of pro-apoptotic CYTOCHROME C gene mutation in common solid cancers and acute leukaemias. Pathology 2009;41:395–6.
   PubMed Web of Science ®Google Scholar
• Togawa K, Yan YX, Inomoto T, Slaugenhaupt S, Rustgi AK. Intestinal cell kinase (ICK) localizes to the crypt region and requires a dual phosphorylation site found in map kinases. J Cell Physiol 2000;183:129–39.
   PubMed Web of Science ®Google Scholar
• Lahiry P, Wang J, Robinson JF, Turowec JP, Litchfield DW, Lanktree MB, A multiplex human syndrome implicates a key role for intestinal cell kinase in development of central nervous, skeletal, and endocrine systems. Am J Hum Genet 2009;84:134–47.
   PubMed Web of Science ®Google Scholar
• Mercurio F, Zhu H, Murray BW, Shevchenko A, Bennett BL, Li J, IKK-1 and IKK-2: cytokine-activated IkappaB kinases essential for NF-kappaB activation. Science 1997;278:860–6.
   PubMed Web of Science ®Google Scholar
• Ismail HA, Lessard L, Mes-Masson AM, Saad F. Expression of NF-kappaB in prostate cancer lymph node metastases. Prostate 2004;58:308–13.
   PubMed Web of Science ®Google Scholar
• Skaug B, Jiang X, Chen ZJ. The role of ubiquitin in NF-kappaB regulatory pathways. Annu Rev Biochem 2009;78:769–96.
   PubMed Web of Science ®Google Scholar
• Sweeney C, Li L, Shanmugam R, Bhat-Nakshatri P, Jayaprakasan V, Baldridge LA, Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. Clin Cancer Res 2004;10:5501–7.
   PubMed Web of Science ®Google Scholar
• Fradet V, Lessard L, Begin LR, Karakiewicz P, Masson AM, Saad F. Nuclear factor-kappaB nuclear localization is predictive of biochemical recurrence in patients with positive margin prostate cancer. Clin Cancer Res 2004;10:8460–4.
   PubMed Web of Science ®Google Scholar
• Ferdinandusse S, Denis S, IJist L, Dacremont G, Waterham HR, Wanders RJ. Subcellular localization and physiological role of alpha-methylacyl-CoA racemase. J Lipid Res 2000;41:1890–6.
   PubMed Web of Science ®Google Scholar
• Cheung PK, Woolcock B, Adomat H, Sutcliffe M, Bainbridge TC, Jones EC, Protein profiling of microdissected prostate tissue links growth differentiation factor 15 to prostate carcinogenesis. Cancer Res 2004;64:5929–33.
   PubMed Web of Science ®Google Scholar